Srđan Dedić

Srđan Dedić

Auto-generated profile, based on publicly available information

Srđan Dedić

Cardiology Clinic, University Clinical Center Serbia, 11000 Belgrade, Serbia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2024
Verified
Journal Article
Open access
PDF file
ADAna Djordjevic Dikic
Ana Djordjevic Dikic
SDSrdjan Dedic
Srdjan Dedic
MPMarica Pivljanin
Marica Pivljanin
VGVojislav Giga
Vojislav Giga
Coronary vasospasm stands as a widely acknowledged and frequent culprit behind chest pain, acute coronary syndrome, and sudden cardiac death, yet it remains a challenging diagnosis. Current guidelines recommend invasive coronary function testing to assess pathophysiology and mechanisms and to define treatment. In reality, this protocol is rarely applied, because it necessitates extended occupation of the cath lab, repetitive administration of nephrotoxic iodine contrast agents, the need for repeated testing on both coronary arteries leading to considerable radiation exposure, and significant direct expenses. The promising perspective for vasospasm testing is a noninvasive approach with advanced echocardiographic techniques, such as transthoracic Doppler echocardiography, with more sensitive indicators of ischemia. Hyperventilation and exercise tests are used for vasospasm directed testing, with assessment of the new parameters: coronary flow velocities and reserve, allowing to see deeper into macro and microvascular pathophysiology. Association between coronary flow, global longitudinal strain and microvascular dysfunction (MVD) and impaired values at hyperemia was previously demonstrated. Reduction in coronary flow velocity (CFV) despite heightened myocardial oxygen consumption and double product during hyperventilation are indicative of coronary vasospasm. Normal coronary angiography finding in patients with documented evidence of ischemia should initiate additional diagnostic testing in order to increase the yield of specific diagnosis in patients with suspected vasospasm, which could help to personalize treatment and prognosis. In order to achieve this, non-invasive provocative stress echocardiography tests should be included in the diagnostic workup. This approach, characterized by its simplicity, feasibility, safety, and efficacy, is currently undergoing extensive testing on a large scale.

1 January 2024 in Srce i krvni sudovi
Verified
Journal Article
Open access
PDF file
STSara Tomović
Sara Tomović
NMNina Miljković
Nina Miljković
ABAnja Bogović
Anja Bogović
TSTomislav Smiljković
Tomislav Smiljković
SDSrđan Dedić
Srđan Dedić
MBMarko Banovic
Marko Banovic
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome characterized by impaired left ventricular filling. It affects approximately 50% of patients with heart failure worldwide. Its complex pathophysiology involves the interaction between cardiomyocyte dysfunction and numerous comorbidities, including older age, female sex, type 2 diabetes, obesity, sleep apnea, hypertension, pulmonary hypertension, chronic obstructive pulmonary disease, coronary artery disease, and atrial fibrillation. Obesity, as a major risk factor, is chronic systemic inflammatory state that induces hemodynamic derangements and hormonal abnormalities that stress the cardiovascular system, with central obesity in women particularly contributing to HFpEF development. Diagnosis relies on clinical evaluation, measurement of natriuretic peptides, echocardiographic assessment, and exercise testing. Therapy includes SGLT-2 inhibitors, GLP-1 agonists, mineralocorticoid receptor antagonists, optimized diuretic therapy, management of comorbidities, lifestyle modifications, and structured exercise, improving prognosis and quality of life for patients.

1 January 2026 in Medicinska istrazivanja
Verified
Journal Article
Open access
PDF file
SASrdjan Aleksandric
Srdjan Aleksandric
NMNina Miljković
Nina Miljković
STSara Tomović
Sara Tomović
ISIvan Soldatovic
Ivan Soldatovic
SJStefan Juricic
Stefan Juricic
MBMarko Banovic
Marko Banovic
Introduction: When to intervene in asymptomatic patients with moderate or severe aortic stenosis (AS) and preserved left ventricular ejection fraction (LVEF) has not yet been determined. In patients with AS, low flow through the aortic valve is defined as indexed stroke volume (SVi) ≤35 ml/m2. Our work aimed to determine the relationship between SVi and all-cause mortality in asymptomatic patients with moderate or severe AS, concordantly high mean gradient across the aortic valve (Pmean), and preserved LVEF. Methods: The study included 121 asymptomatic patients (69 men, mean age 66±11) with moderate-to-severe AS (aortic valve area ≤1.5 cm2), concordantly high Pmean (≥30 mmHg), and preserved LVEF (≥50%). The median follow-up was 38 months (IQR 35-42 months). Results: Ten patients (8%) died during the follow-up. All-cause mortality was significantly higher in the group of AS-patients with SVi ≤35 ml/m2 compared to those with SVi >35 ml/m2 (15% vs. 4%, p=0.045). The cumulative incidence of all-cause mortality was significantly higher in the group of AS-patients with SVi ≤35 ml/m2 compared to those with SVi >35 ml/m2 (log-rank p=0.035). The group of AS-patients with SVi ≤35 ml/m2 had a 3.8-fold higher risk of all-cause mortality during long-term follow-up compared with those with SVi >35 ml/m2 (HR: 3.845; 95% CI: 1.004-14.871; p=0.041). Conclusion: Left ventricular SVi may be a significant predictor of all-cause mortality during long-term follow-up in asymptomatic patients with moderate or severe AS, concordantly elevated Pmean, and preserved LVEF. Larger studies are needed to confirm these findings.

1 January 2020 in Srce i krvni sudovi
Verified
Journal Article
Closed access
MPMarica Pivljanin
Marica Pivljanin
VGVojislav Giga
Vojislav Giga
SDSrđan Dedić
Srđan Dedić
FMFilip Marković
Filip Marković
VMVarbusova Mihajlović
Varbusova Mihajlović
AĐAna Đorđević-Dikić
Ana Đorđević-Dikić
Background. Although percutaneous coronary intervention (PCI) is the gold standard in the treatment of acute myocardial infarction with ST elevation, its role in the treatment of patients with chronic coronary syndrome versus optimal medicament therapy (OMT) is not clearly defined. Case report. We present a diabetic patient with typical chest pain and large area of ischemia on stress echocardiography and at high risk of adverse cardiac events who was on intensive OMT for 5 years with good control of the symptoms and without adverse cardiac events. Conclusion. Despite the advances in the invasive treatment of chronic coronary syndrome, the intensive OMT has a key role in treatment of such patients.

1 January 2019 in Srce i krvni sudovi
Verified
Journal Article
Closed access
MKMarija Kotevska
Marija Kotevska
SDSrđan Dedić
Srđan Dedić
MPMarica Pivljanin
Marica Pivljanin
VGVojislav Giga
Vojislav Giga
MTMilorad Tesic
Milorad Tesic
AĐAna Đorđević-Dikić
Ana Đorđević-Dikić
Background: An inconclusive or non-diagnostic stress echocardiography test (SET) implies a need for additional tests, which often results in unnecessary invasive examinations and higher health costs. Aim: The aim of our study was to investigate the value of non-invasive transthoracic Doppler echocardiography (TTDE) derived coronary flow reserve (CFVR) in patients with non-diagnostic and inconclusive SET. Methods: The study group consisted of 122 patients (73 male, 49 females: mean age 63±8 years) with non-diagnostic SET (target heart rate (HR) not reached, chest pain without electrocardiographic (ECG) and echocardiographic changes; and inconclusive SET (target HR reached, chest pain without ECG and echocardiographic changes). All patients were referred for TTDE assessment of CFVR in left anterior descending artery (LAD). CFVR was calculated as the ratio of maximal hyperemic and baseline coronary flow velocity. CFVR LAD ≤ 2 was considered abnormal. All patients were scheduled for invasive coronary angiography (CA). Results: Mean CFVR LAD was 2.4±0.44. CFVR LAD was abnormal in 22 (18%) and preserved in 100 (82%) patients. Significant LAD stenosis was found in 15 (12.2%) out of 122 patients. Sensitivity of reduced CFVR LAD ≤ 2 was 88% for significant LAD stenosis, while preserved CFVR >2 had negative predictive value of 95%. Correlation analysis found significant correlation between invasive CA and CFVR LAD (r -0.356; p<0.0001). Conclusions: Reduced CFVR LAD ≤ 2.0 has additive diagnostic value in detection of significant LAD stenosis in patients with non-diagnostic and inconclusive SET.

1 January 2025 in Srce i krvni sudovi
Verified
Journal Article
Open access
PDF file
SDS. Dedić
S. Dedić
Viseslav PopadicViseslav Popadic
Viseslav Popadic
MPMarica Pivljanin
Marica Pivljanin
VGVojislav Giga
Vojislav Giga
Marija ZdravkovićMarija Zdravković
Marija Zdravković
AĐA. Đorđević-Dikić
A. Đorđević-Dikić
Introduction: Coronary microvascular dysfunction (CMD) causes angina in patients with non-obstructive coronary arteries (ANOCA) due to structural and functional microcirculation abnormalities. Although invasive testing is the gold standard, its use is limited. Non-invasive methods like hyperventilation combined with exercise stress echocardiography offer practical, accessible assessment of coronary vasomotor function and CMD detection. Case report: We present a case of a 55-year-old woman with longstanding exertional chest pain, fatigue, and dyspnea, who remained undiagnosed despite normal findings on coronary CT and invasive angiography. Invasive testing with acetylcholine was not performed. Due to persistent symptoms, she underwent non-invasive evaluation using a combined hyperventilation and exercise stress echocardiography protocol. The test revealed a drop in coronary flow velocity after hyperventilation and inadequate coronary flow velocity reserve (CFVR <2) at peak exercise, with accompanying ST depression and subtle wall motion abnormalities-indicative of microvascular vasospasm. Cardiac magnetic resonance imaging (CMR) using adenosine and hyperventilation protocols confirmed widespread subendocardial perfusion defects, supporting a diagnosis of mixed-type CMD with both functional and structural components. Treatment with a calcium channel blocker, ranolazine, and statin led to marked symptom improvement. Conclusion: This case highlights the diagnostic value of non-invasive methods-particularly hyperventilation stress echocardiographic test, further confirmed by CMR.